UNSPSC 51242104: Phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE501. This VA Drug Class (RE501) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT.

UNSPSC 51242104 Phenylephrine/pyrilamine is a Commodity code that encompasses specific active pharmaceutical ingredients and combination OTC products distributed through state and local government healthcare and institutional facilities. State and local governments buy these products primarily through cooperative purchasing agreements established with multiple manufacturers and wholesalers to serve participating agencies' clinical and operational needs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body active under this code, procuring pharmaceuticals across multiple participating state and local jurisdictions including Oregon. Vendors responding to this code must demonstrate current Good Manufacturing Practice (cGMP) certification, Drug Supply Chain Security Act (DSCSA) compliance, and the ability to supply products through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) with established chargeback systems. Responses require detailed product specifications including National Drug Codes (NDC), SKUs, UPCs, generic descriptions, strength, dosage form, and manufacturing locations, along with pricing flexibility through formats such as flat price, net price (NF30, NF60, NF90), or WAC-minus structures.

MMCAP's RFP for Generic Multi Source Pharmaceuticals and OTC Products (solicitation S1070000015802), due March 26, 2026, covers multi-state distribution across participating government facilities in Minnesota, Oregon, and other member jurisdictions. The cooperative structure distributes awarded products to authorized wholesalers effective July 1, 2026, with evaluation weighted heavily toward price competitiveness (75 percent), supported by compliance with administrative fees (5 percent), EDI capability (5 percent), fixed pricing terms (10 percent), and agreement to a 3 percent administrative fee (5 percent). Vendors must maintain comprehensive insurance including $5,000,000 commercial general liability per occurrence, $2,000,000 network security and privacy liability, and $2,000,000 professional liability. The contract term extends two years for new responders with optional extensions, while incumbents align with existing expiration dates through June 30, 2028. Performance penalties ranging from $200 to $1,500 per violation apply for late reporting, missed onboarding timelines, and improper class-of-trade denials.